Guoji laonian yixue zazhi (Mar 2024)

Risk Factors of Bleeding after Subcutaneous Injection of Low-molecular-weightHeparin in Elderly Patients with Unstable Angina Pectoris and Asthenia

  • Qi Wu,
  • Meili Ji,
  • Rong Zhang,
  • Danlei Wang,
  • Peipei Xia

DOI
https://doi.org/10.3969/j.issn.1674-7593.2024.02.004
Journal volume & issue
Vol. 45, no. 02
pp. 147 – 151

Abstract

Read online

Objective To analyze the risk factors of bleeding after subcutaneous injection of low-molecular-weight heparin in elderly patients with unstable angina pectoris and weakness. Methods Elderly patients with unstable angina pectoris and weakness who were hospitalized in the Department of Geriatrics and the Department of Cardiology of Nanjing Hospital Affiliated to Nanjing Medical University(Nanjing First Hospital) from June 2020 to June 2023, they were randomly divided into subcutaneous hemorrhage group(n=90) and control group(n=90) according to whether subcutaneous hemorrhage occurred.General data such as age, gender, body mass index(BMI), as well as combined diseases and injection methods were compared between the two groups.Multivariate logistic regression was performed to analyze the risk factors for subcutaneous hemorrhage after subcutaneous injection of low-molecular-weight heparin. Results The BMI, proportion of patients who underwent compression after injection of low-molecular-weight heparin, and subcutaneous fat thickness of patients in the subcutaneous hemorrhage group were significantly lower than those in the control group, with statistical significance(P<0.05).Multivariate logistic regression results showed that low subcutaneous fat thickness, low BMI and no pressing after needle withdrawal were independent risk factors of subcutaneous hemorrhage after subcutaneous injection of low-molecular-weight heparin in patients(P<0.05). Conclusion Low subcutaneous fat thickness, low BMI and no injection point compression after needle withdrawal are independent risk factors for the risk of subcutaneous hemorrhage in elderly patients with unstable angina pectoris and associated weakness after subcutaneous injection of low-molecular-weight heparin.In the clinical application of low-molecular-weight heparin, attention should be paid to control blood pressure or increase compression time, thereby reducing the risk of subcutaneous hemorrhage in patients.

Keywords